Michael Fehlings
Co-founder / Director Scientific Affairs at ImmunoScape | San Diego, California, United States
Michael Fehlings’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
PHD Researcher at Charité Berlin in August 2026 - August 2026
PHD Researcher at Max Planck Institute for Infection Biology in August 2026 - August 2026
Research Assistant at University of Konstanz in August 2026 - August 2026
Humboldt-Universität zu Berlin (Humboldt University of Berlin), Doctor of Philosophy - PhD
University of Konstanz, Master of Science (Diploma)
ImmunoScape is transforming cancer therapy with its novel Seed-and-Boost approach, which combines our proprietary optimised TCR T cells with clinically-validated Immuno-STAT T cell engagers. This pioneering approach addresses the shortcomings of current cell therapies by enabling potent in vivo expansion of infused tumor targeting T-cells. Our combination therapy has the potential to transform cell therapy, through the delivery of safe, tolerable and effective therapies against cancer while simplifying the patient journey. We are currently advancing IND-enabling studies and accelerating entry into the clinic.
Discover more about ImmunoScapeSenior Scientist working to develop the next generation of TCR therapies. Cellular therapy. Cancer immunotherapy.
PhD Candidate at Pontificia Universidad Javeriana
(August 2026 – August 2026)
Senior Director, Computational Biology, ImmunoScape
Senior Cloud Solution Architect at Microsoft
(August 2026 – August 2026)
Associate Director @ ImmunoScape | Tumor-specific TCR Discovery, Immunology, Chemical Biology, Proximity Reactions, Click Chemistry, Preclinical Study
Postdoctoral Researcher at The Scripps Research Institute
(August 2026 – August 2026)
Intellectual Property | Alliance Management | Business Development | Biotech Director, Contracts & IP
Associate Director at Duke-NUS Medical School
(August 2026 – August 2026)
Associate Director of Operations at ImmunoScape
Operations Team Lead at ImmunoScape
(August 2026 – Present)
Group Chief Financial Officer at ImmunoScape
Group Chief Financial Officer at ImmunoScape
(August 2026 – Present)
What is Michael Fehlings email address?
Email Michael Fehlings at [email protected]. This email is the most updated Michael Fehlings's email found in 2026.
What is Michael Fehlings phone number?
Michael Fehlings phone number is 7608390064 and 2087042119.
How to contact Michael Fehlings?
To contact Michael Fehlings send an email to [email protected]. If you want to call Michael Fehlings try calling on 7608390064 and 2087042119.
What company does Michael Fehlings work for?
Michael Fehlings works for ImmunoScape.
What is Michael Fehlings's role at ImmunoScape?
Michael Fehlings is Co-founder / Director Scientific Affairs
What industry does Michael Fehlings work in?
Michael Fehlings works in the Biotechnology industry.